Berthold Langguth is an expert in Neurology at University of Regensburg (Germany). As of October 2026, ScienceLeadR ranks Berthold Langguth in the top 1% of experts worldwide for Hearing Disorders, Hearing Loss and Psychological Techniques. Berthold Langguth has authored 588 publications, the most recent in 2026, and is an investigator in 39 clinical trials, 5 of them ongoing. SLR score: 2,235 (community average: 125). How the SLR is computed.

LeadR Profile

Berthold Langguth University of Regensburg Germany
2 235 ScienceLeadR Reputation 2235
Network Map

Neurology

Subspecialties: Psychiatry - Otolaryngology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026

Source: PubMed

University of Regensburg

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Theta burst stimulation with 80 and 120% resting motor threshold do not differ in their antidepressant efficacy: a retrospective analysis.
PMID 42799904 — depression, antidepressive agents, therapeutics, nervous system diseases, neurology, psychiatry
Eur Arch Psychiatry Clin Neurosci20260
The longer, the better? Investigating the effect of prolonged acoustic stimulation on brief acoustic tinnitus suppression.
PMID 42380788 — tinnitus, acoustics, acoustic stimulation, research, nervous system diseases
BMC Neurol20260
Antagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trial.
PMID 42303794 — memory, short-term, pharmaceutical preparations, schizophrenia, therapeutics, memory, spironolactone
Commun Med (Lond)20262
Trajectory of COVID-related tinnitus over the pandemic timeline.
PMID 42302460 — tinnitus, signs and symptoms, pandemics, severe acute respiratory syndrome-related coronavirus, infections
Braz J Otorhinolaryngol20260
Tinnitus and tinnitus disorder: Genetic, neurobiological, and clinical differentiation.
PMID 42291209 — tinnitus, genetics, psychiatry
iScience20262

Clinical Studies 39

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 26 Study Chair: 1 Study Director: 1

By phase:

N/A 36
Phase 1/Phase 2 1
Phase 2 1
Phase 4 1

By status:

Completed 30
Active not recruiting 3
Recruiting 3
Terminated 3

By type:

Interventional 38
Observational 1

By Monocentric/Multicentric:

monocentric 32
multicentric2to4 5
multicentric5to9 1
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Accelerated Treatment of Depressive Patients With tDCS
NCT07444242 — depression, antidepressive agents, transcranial direct current stimulation, mental disorders, brain, transcranial magnetic stimulation, depressive disorder, research, therapeutics, outpatients, depressive disorder, major
N/ARecruiting2026
Application of Direct Current Transcranial stImulation Remotely superVised in Chronic fATiguE
NCT05791812 — transcranial direct current stimulation, encephalomyelitis, fatigue syndrome, chronic, fatigue
N/AActive not recruiting2023
Theta Burst Stimulation in Pharmacologically Untreated Patients as Sole Antidepressant Treatment
NCT05732298 — depression, antidepressive agents, transcranial magnetic stimulation, therapeutics, pulse
N/AActive not recruiting2023
Intermittent Theta Burst Stimulation for Maintenance Therapy in Depression
NCT05732311 — depression, maintenance, therapeutics
N/ARecruiting2023
High dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction
NCT05738174 — alcoholism, therapeutics, pulse
N/ARecruiting2023

LeadR Networks

Main global connection map